Epirubicin is classified as an anthracycline antibiotic and is preferred for its significantly lower cardiotoxicity which makes it safer for elderly patients with breast cancer. Indication: As a component of adjuvant therapy in patients with evidence of axillary node tumor involvement following resection of primary breast cancer
Member Since 10 Years
Nature of Business Retailer
For Buyer 
For Seller 
Help 
Malviya Nagar, Delhi